Invention Grant
- Patent Title: Cancer vaccine compositions and methods of use thereof
-
Application No.: US15327225Application Date: 2015-07-17
-
Publication No.: US10759836B2Publication Date: 2020-09-01
- Inventor: Mary L. Disis , Elizabeth Broussard
- Applicant: UNIVERSITY OF WASHINGTON
- Applicant Address: US WA Seattle
- Assignee: UNIVERSITY OF WASHINGTON
- Current Assignee: UNIVERSITY OF WASHINGTON
- Current Assignee Address: US WA Seattle
- Agency: canady + lortz LLP
- Agent Karen S. Canady
- International Application: PCT/US2015/040960 WO 20150717
- International Announcement: WO2016/011386 WO 20160121
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K48/00 ; C07K14/82 ; C12N15/09 ; C12N5/09 ; C07K14/78 ; C12N9/16 ; C07K14/71 ; A61K39/00 ; C07K7/00 ; C07K14/00
Abstract:
The present application describes compositions that include an epitope of a peptide that elicits an immune response in a subject following administration. The compositions described herein include nucleic acids. The present application also describes compositions that include peptides. Also described herein are methods that include administering a composition comprising an epitope of a peptide to a subject in need thereof.
Public/Granted literature
- US20170283475A1 CANCER VACCINE COMPOSITIONS AND METHODS OF USE THEREOF Public/Granted day:2017-10-05
Information query
